These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8323419)

  • 1. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.
    van der Meer FJ; Rosendaal FR; Vandenbroucke JP; Briët E
    Arch Intern Med; 1993 Jul; 153(13):1557-62. PubMed ID: 8323419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.
    van der Meer FJ; Rosendaal FR; Vandenbroucke JP; Briët E
    Thromb Haemost; 1996 Jul; 76(1):12-6. PubMed ID: 8819244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.
    Gadisseur AP; van der Meer FJ; Adriaansen HJ; Fihn SD; Rosendaal FR
    Br J Haematol; 2002 Jun; 117(4):940-6. PubMed ID: 12060134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal intensity of oral anticoagulant therapy after myocardial infarction.
    Azar AJ; Cannegieter SC; Deckers JW; Briët E; van Bergen PF; Jonker JJ; Rosendaal FR
    J Am Coll Cardiol; 1996 May; 27(6):1349-55. PubMed ID: 8626943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.
    Maagdenberg H; Bierings MB; van Ommen CH; van der Meer FJM; Appel IM; Tamminga RYJ; de Boer A; Maitland-van der Zee AH
    J Thromb Haemost; 2018 Jan; 16(1):116-124. PubMed ID: 29108090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
    G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Thromb Haemost; 2004 Jul; 92(1):61-6. PubMed ID: 15213846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanical heart valve patients can manage oral anticoagulant therapy themselves.
    Christensen TD; Andersen NT; Attermann J; Hjortdal VE; Maegaard M; Hasenkam JM
    Eur J Cardiothorac Surg; 2003 Mar; 23(3):292-8. PubMed ID: 12614796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.
    Steffensen FH; Kristensen K; Ejlersen E; Dahlerup JF; Sørensen HT
    J Intern Med; 1997 Dec; 242(6):497-503. PubMed ID: 9437411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding risk factors in chronic oral anticoagulation with acenocoumarol.
    Casais P; Sánchez Luceros A; Meschengieser S; Fondevila C; Santarelli MT; Lazzari MA
    Am J Hematol; 2000 Apr; 63(4):192-6. PubMed ID: 10706762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.
    van Rein N; Lijfering WM; Bos MH; Herruer MH; Vermaas HW; van der Meer FJ; Reitsma PH
    PLoS One; 2016; 11(12):e0164485. PubMed ID: 27935941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
    ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW
    Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
    Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
    Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.